Ozempic, a medication used to treat type 2 diabetes and promote weight loss, has gained popularity within the pharmaceutical market due to its effectiveness in managing blood sugar levels. This trend reflects a broader focus on health and wellness among consumers.
The rise in use of GLP-1 drugs, which includes Ozempic, has implications for various sectors within the US retail market, such as grocery and apparel. Companies like Hershey, Lululemon Athletica, Mondelēz International, NIKE, PepsiCo, and Walmart may be affected by this trend.
This report is exclusive to subscribers only and provides insights into the effects of widespread GLP-1 drug use on the retail industry. Subscribers can access the document by logging in. If you are not a subscriber, you can learn more about subscriptions and access to relevant research.